⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28363985 | 0.96 | — | — | |
| SCHEMBL9438540 | 0.96 | — | — | |
| Bromide SCHEMBL11113762 | 0.96 | — | — | |
| Bromide SCHEMBL28610589 | 0.96 | — | — | |
| SCHEMBL4870608 | 0.80 | TDP1 (0.36) | — | |
| SCHEMBL15155181 | 0.71 | ALDH1A1 (0.72) | — | |
| SCHEMBL2583275 | 0.70 | — | — | |
| SCHEMBL1725494 | 0.67 | — | — | |
| SCHEMBL644381 | 0.64 | — | — | |
| SCHEMBL4822004 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220125834-A1 | LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | Nostopharma, LLC | 2022-04-28 | — | — | US | claimed |
| EP-3937658-A1 | LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | Nostopharma, LLC (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2020185784-A1 | LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | Nostopharma, LLC (US) | 2020-09-17 | — | — | WO | claimed |
| EP-3681481-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HETEROTOPIC OSSIFICATION AND PATHOLOGIC CALCIFICATION | Nostopharma, LLC (US) | 2020-07-22 | — | — | EP | claimed |
| WO-2019055064-A9 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HETEROTOPIC OSSIFICATION AND PATHOLOGIC CALCIFICATION | Nostopharma, LLC (US) | 2020-06-18 | — | — | WO | claimed |
| US-10548908-B2 | Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification | Nostopharma, LLC (US) | 2020-02-04 | — | — | US | claimed |
| US-10456409-B2 | Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification | Nostopharma, LLC (US) | 2019-10-29 | — | — | US | claimed |
| EP-2964672-B1 | SPECIFIC DETECTION TOOL FOR MESENCHYMAL AND EPITHELIAL-MESENCHYMAL TRANSFORMED CIRCULATING TUMOR CELLS | UNIV TEXAS (US) | 2019-10-09 | — | — | EP | claimed |
| US-20190175621-A1 | Compositions and Methods for Preventing and Treating Heterotopic Ossification and Pathologic Calcification | Nostopharma, LLC (US) | 2019-06-13 | — | — | US | claimed |
| WO-2019055064-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HETEROTOPIC OSSIFICATION AND PATHOLOGIC CALCIFICATION | Nostopharma, LLC (US) | 2019-03-21 | — | — | WO | claimed |
| EP-0728009-B1 | USE OF AN AGENT WHICH MODULATES TYROSINE PHOSPHORYLATION FOR MODULATING THE PERMEABILITY OF A PSYCHOLOGICAL BARRIER | EISAI CO LTD (JP) | 2003-01-22 | — | — | EP | claimed |
| EP-1274879-A1 | A PROCESS FOR THE PURIFICATION OF ORGANOMETALLIC COMPOUNDS OR HETEROATOMIC ORGANIC COMPOUNDS WITH HYDROGENATED GETTER ALLOYS | SAES GETTERS S.p.A. (IT) | 2003-01-15 | — | — | EP | claimed |
| WO-2001078869-A9 | A PROCESS FOR THE PURIFICATION OF ORGANOMETALLIC COMPOUNDS OR HETEROATOMIC ORGANIC COMPOUNDS WITH A PALLADIUM-BASED CATALYST | GETTERS SPA (IT) | 2002-07-18 | — | — | WO | claimed |
| WO-2001079586-A9 | A PROCESS FOR THE PURIFICATION OF ORGANOMETALLIC COMPOUNDS OR HETEROATOMIC ORGANIC COMPOUNDS WITH A CATALYST BASED ON IRON AND MANGANESE SUPPORTED ON ZEOLITES | GETTERS SPA (IT) | 2002-07-18 | — | — | WO | claimed |
| WO-2001078869-A1 | A PROCESS FOR THE PURIFICATION OF ORGANOMETALLIC COMPOUNDS OR HETEROATOMIC ORGANIC COMPOUNDS WITH A PALLADIUM-BASED CATALYST | SAES GETTERS S.P.A. (IT) | 2001-10-25 | — | — | WO | claimed |
| WO-2001079587-A1 | A PROCESS FOR THE PURIFICATION OF ORGANOMETALLIC COMPOUNDS OR HETEROATOMIC ORGANIC COMPOUNDS WITH HYDROGENATED GETTER ALLOYS | SAES GETTERS S.P.A. (IT) | 2001-10-25 | — | — | WO | claimed |
| US-5459097-A | Using a masked substrate; decomposition of an organoaluminum compound | AT&T CORP. (US) | 1995-10-17 | — | — | US | claimed |
| EP-0337304-B1 | Use of monophenylarsines or diphenylarsines for the preparation of epitaxial layers in the gas phase | PREUSSAG PURE METALS GMBH (DE) | 1994-01-05 | — | — | EP | claimed |
| EP-0544437-A2 | Method for selectively growing aluminum-containing layers | AT&T Corp. (US) | 1993-06-02 | — | — | EP | claimed |
| US-5004821-A | Used In Epitaxy Processes For Production Of Semiconductors; Reduction Of Phenylarsonic Acid With Zinc | PPM PURE METALS GMBH (DE) | 1991-04-02 | — | — | US | claimed |